BNBX vs CFLT · P/E 0.0, rev $2.2M vs rev $963.6M
Applied DNA Sciences, Inc. (BNBX) versus Confluent Inc (CFLT) — a side-by-side from cached financials, not a winner call.
Applied DNA Sciences, Inc. (BNBX) is a asset management company listed on NASDAQ.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Latest reported BNBX revenue for 2026-06-30 was $2.2M. Net income was -$29.9M. Revenue was up 38.1% from 2026-03-31 to 2026-06-30. BNBX currently screens at market cap $3.3M and trailing P/E 0.0.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
BNBX currently screens at market cap $3.3M and trailing P/E 0.0. CFLT currently screens at market cap $11.13B.
Not investment advice. Open the BNBX and CFLT stock pages for the full models.
Not investment advice.